PROK’s -11.43% Loss This Week Has Revealed Something We Didn’t Know Before
During the last session, ProKidney Corp (NASDAQ:PROK)’s traded shares were 0.39 million, with the beta value of the company hitting 1.31. At the end of
During the last session, ProKidney Corp (NASDAQ:PROK)’s traded shares were 0.39 million, with the beta value of the company hitting 1.31. At the end of
ProKidney Corp (NASDAQ:PROK)’s traded shares stood at 0.43 million during the last session, with the company’s beta value hitting 1.31. At the close of trading,
ProKidney Corp (NASDAQ:PROK)’s traded shares stood at 1.16 million during the last session, with the company’s beta value hitting 1.30. At the close of trading,
In last trading session, ProKidney Corp (NASDAQ:PROK) saw 0.57 million shares changing hands with its beta currently measuring 1.11. Company’s recent per share price level
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.